Skip to main content

People in the News: Jean-Pol Detiffe, Pierre Lefesvre

Premium

Jean-Pol Detiffe has founded and will serve as CEO of OncoDNA, a new subsidiary of the Institute of Pathology and Genetics in Gosselies, Belgium (see story, this issue).

Detiffe founded and was previously CEO of DNAVision. He was also project and business development manager of Bio.be, also part of the Institute of Pathology and Genetics, and has served on the boards of DNALytics, Immune Health, Biowin, and DNAVision Agrifood.

Additionally, Pierre Lefesvre will serve as OncoDNA's medical director.

He is a medical pathologist at IPG.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.